Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery

OBJECTIVES: To clarify the work done by using AI for identifying the genomic sequences, development of drugs and vaccines for COVID-19 and to recognize the advantages and challenges of using such technology. METHODS: A non-systematic review was done. All articles published on Pub-Med, Medline, Googl...

Descripción completa

Detalles Bibliográficos
Autores principales: Abubaker Bagabir, Sali, Ibrahim, Nahla Khamis, Abubaker Bagabir, Hala, Hashem Ateeq, Raghdah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767913/
https://www.ncbi.nlm.nih.gov/pubmed/35078755
http://dx.doi.org/10.1016/j.jiph.2022.01.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767913/
https://www.ncbi.nlm.nih.gov/pubmed/35078755
http://dx.doi.org/10.1016/j.jiph.2022.01.011

Ejemplares similares